Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson Progress
0% Complete
Diagnosis and Classification of Delirium in the ICU

Diagnosis and Classification of Delirium in the ICU

Objectives Icon A checkmark inside a circle, symbolizing achieved goals.

Learning Objective

Apply diagnostic and classification criteria to assess delirium in critically ill patients and guide initial management.

1. Introduction and Clinical Imperative

Delirium is an acute, fluctuating disturbance of attention and cognition that represents a form of organ dysfunction of the brain. It affects up to 80% of mechanically ventilated patients in the intensive care unit (ICU) and is independently associated with increased mortality, prolonged mechanical ventilation, extended hospital stays, and significant long-term cognitive impairment resembling dementia.

Despite its prevalence and severe consequences, delirium is frequently missed. Unstructured bedside assessments fail to detect up to 60% of cases, particularly the non-agitated, hypoactive subtype. The pathogenesis is complex, involving neurotransmitter imbalances (e.g., acetylcholine, dopamine), systemic inflammation crossing the blood-brain barrier, and profound disruption of the normal sleep-wake cycle. Therefore, integrating validated screening tools and a structured diagnostic work-up into daily ICU workflow is not merely best practice—it is a critical patient safety imperative.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. The “Quiet” Danger

Hypoactive delirium, characterized by lethargy and inattention, accounts for approximately 50% of all delirium cases in the ICU. Without formal screening, it is often misclassified as appropriate sedation, depression, or fatigue, leading to missed opportunities for intervention and worse patient outcomes.

2. Confusion Assessment Method for the ICU (CAM-ICU)

The CAM-ICU is a rapid, validated, and widely used bedside tool for delirium screening in critically ill adults. It has demonstrated excellent performance, with a sensitivity of 93–100% and a specificity of 89–100% in diverse ICU populations. The assessment is designed to be performed by nurses or other trained clinicians in under two minutes.

2.1 Diagnostic Criteria and Administration

The CAM-ICU evaluates four key features. A patient is considered CAM-ICU positive (i.e., delirious) if they exhibit Feature 1 AND Feature 2, plus EITHER Feature 3 OR Feature 4.

CAM-ICU Diagnostic Features
Feature Assessment Criteria
1. Acute Onset or Fluctuating Course Is there evidence of an acute change in mental status from baseline, or has the patient’s mental status fluctuated during the past 24 hours? (Source: family, chart, nursing report)
2. Inattention Does the patient have difficulty focusing attention? (Assessed via standardized letter or picture recognition tasks. More than 2 errors indicates a positive feature.)
3. Altered Level of Consciousness Is the patient’s current level of consciousness anything other than “alert and calm”? (Assessed using the Richmond Agitation-Sedation Scale [RASS]; any score other than 0 is positive for this feature).
4. Disorganized Thinking Is the patient’s thinking disorganized? (Assessed by asking simple yes/no questions and testing for a logical command. More than 1 error indicates a positive feature.)

2.2 Common Pitfalls and Training

Accurate use of the CAM-ICU requires structured training and consistent application. Common pitfalls include attempting to assess deeply sedated or comatose patients (RASS –4 or –5, who are “unable to be assessed”), language barriers interfering with the inattention task, and inconsistent delivery of the standardized questions. To ensure high fidelity, institutions should implement formal training with didactics, video examples, and supervised practice, followed by annual competency checks. High inter-rater reliability (κ ≥ 0.8) is achievable with this approach.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Embedding CAM-ICU in the Workflow

The most effective way to ensure consistent delirium screening is to integrate it directly into the electronic health record (EHR). Building mandatory CAM-ICU assessment prompts into nursing flowsheets, linked to RASS documentation, dramatically increases compliance and improves the rate of delirium detection across an institution.

3. Intensive Care Delirium Screening Checklist (ICDSC)

The ICDSC is an alternative validated tool that uses an 8-item checklist based on observations over an entire nursing shift. It provides an ordinal score from 0 to 8, with a score of 4 or greater indicating the presence of delirium. While the CAM-ICU provides a binary (yes/no) result, the ICDSC can also be used to track the severity of delirium over time.

3.1 Scoring Items and Thresholds

Each of the following eight items is scored as 1 point if present during the shift:

  • Altered level of consciousness
  • Inattention
  • Disorientation
  • Hallucinations, delusions, or psychosis
  • Psychomotor agitation or retardation
  • Inappropriate speech or mood
  • Sleep-wake cycle disturbance
  • Symptom fluctuation

A total score of 4 or more is diagnostic for delirium. A score of 1-3 suggests subsyndromal delirium.

3.2 Validation and Integration

The ICDSC has a reported sensitivity of approximately 74% and a specificity of 82% in mixed ICU populations. While its diagnostic accuracy is slightly lower than the CAM-ICU, its strength lies in its ability to quantify delirium severity. Worsening scores can trigger specific interventions, and improving scores can demonstrate response to therapy. The ICDSC should be completed at least every 12 hours and can be easily integrated into routine nursing assessments, with EHR calculators and alerts to flag high-scoring patients.

4. Additional Tools and Emerging Scales

While the CAM-ICU and ICDSC are the most robustly validated tools for the ICU setting, several other instruments exist. These are primarily used in non-ICU settings or are still under investigation for widespread ICU use.

  • 3D-CAM: A 3-minute, structured adaptation of the CAM algorithm, well-validated for emergency department and hospital ward settings but less studied in ventilated patients.
  • 4AT: A rapid (<2 minute) tool that combines alertness, orientation, attention, and acute change assessment. It is highly effective in older, non-ICU patients, but its validity in critically ill populations remains to be established.
  • Cornell Scale for Depression in Dementia: This is a specialized tool for assessing mood in patients with pre-existing cognitive deficits and is not designed for acute delirium diagnosis.

Editor’s Note: Detailed comparative accuracy data for tools like the 3D-CAM and 4AT specifically within ventilated ICU subpopulations are limited. A comprehensive evaluation would require dedicated studies assessing their performance metrics against the CAM-ICU across different age groups, sedation levels, and primary diagnoses, along with data on training requirements and inter-rater reliability in the critical care environment.

5. Laboratory and Imaging Assessment

Once delirium is identified, a targeted work-up is essential to uncover and reverse contributing factors. This should be a systematic but judicious process, avoiding a “shotgun” approach.

5.1 Foundational Metabolic and Infectious Work-Up

The initial investigation should focus on common, reversible causes:

  • Metabolic Panel: Check for electrolyte abnormalities (sodium, calcium, magnesium), renal failure (BUN, creatinine), and glucose dysregulation.
  • Liver Function: Assess for hepatic encephalopathy with LFTs and an ammonia level if suspected.
  • Infection Markers: A CBC with differential, CRP, or procalcitonin can signal infection. Obtain blood, urine, and other relevant cultures as clinically indicated.
  • Oxygenation: An arterial blood gas can reveal hypoxemia or hypercarbia.
  • Medication Review: Conduct a thorough review of all medications, especially sedatives (benzodiazepines), analgesics (opioids), and anticholinergic agents, which are common culprits. A toxicology screen may be warranted.

5.2 Escalated Neurologic Evaluation

Advanced neuroimaging and EEG are not routine for all delirium cases. They should be reserved for patients with specific “red flag” findings:

  • CT or MRI of the Head: Indicated for new focal neurologic deficits (e.g., unilateral weakness), recent head trauma, or delirium that persists for days despite correction of all metabolic and infectious causes.
  • Electroencephalogram (EEG): Indicated for suspected nonconvulsive seizures, particularly in patients with profound and unexplained altered mental status. In non-seizure encephalopathy, EEG typically shows generalized slowing or triphasic waves.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Image Wisely

Avoid routine head CT scans for every patient with delirium. The diagnostic yield is very low in the absence of focal neurologic signs or a history of trauma. A targeted approach based on red flags optimizes resource utilization and minimizes unnecessary radiation exposure and patient transport.

6. Subtype Differentiation and Clinical Implications

Delirium is not a monolithic entity. It presents with distinct motoric subtypes—hyperactive, hypoactive, and mixed—each with different clinical features, prognoses, and management priorities.

Hyperactive IconIcon showing agitated movement.

Hyperactive

Characterized by agitation, restlessness, and emotional lability. Patients may attempt to remove lines and tubes, posing a safety risk. This is the most recognized but least common subtype.

Hypoactive IconIcon showing a person in a calm, still state.

Hypoactive

Characterized by lethargy, apathy, and reduced motor activity. Patients are inattentive and withdrawn. This is the most common subtype and is associated with the highest mortality.

Mixed IconIcon showing a circular arrow, indicating fluctuation.

Mixed

Features fluctuations between hyperactive and hypoactive states throughout the day. This subtype is also very common and requires dynamic assessment and management.

Management Implications

Recognizing the subtype guides initial management. Hyperactive delirium requires immediate focus on patient safety, including environmental modifications and, if necessary, judicious use of pharmacotherapy per sedation guidelines. In contrast, hypoactive delirium management centers on reviewing and reducing sedative medications, promoting early mobility and physical therapy, optimizing the sleep-wake cycle, and engaging family for reorientation.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Unmasking Hypoactive Delirium

Daily sedation interruption trials (spontaneous awakening trials) are a powerful diagnostic and therapeutic tool. By temporarily stopping sedatives, clinicians can “unmask” an underlying hypoactive delirium that was being obscured by medication, allowing for a true assessment of neurologic function and preventing sedative accumulation.

7. Diagnostic Pathway Algorithm

A standardized pathway ensures consistent screening, evaluation, and management. It facilitates clear communication and timely, multidisciplinary interventions.

Delirium Diagnostic Pathway Algorithm A flowchart showing the steps for delirium management in the ICU. It starts with routine screening, moves to etiologic workup if positive, then to non-pharmacologic and pharmacologic interventions, and finally to reassessment. 1. Screen Patient CAM-ICU or ICDSC Every 8-12h Positive? YES NO Continue Routine Screening 2. Etiologic Work-Up Review Meds (THINK) Check Labs (Metabolic) Rule out Infection 3. Intervene Non-Pharmacologic First: Mobility, Sleep, Reorient Pharmacologic (If Safety Risk): Targeted, low-dose agents 4. Communicate & Reassess Discuss in Rounds Notify Family
Figure 1: A Stepwise Diagnostic and Management Pathway for ICU Delirium. This approach begins with routine, validated screening. A positive screen triggers a systematic search for reversible causes, followed by a primary focus on non-pharmacologic interventions. The process is iterative, requiring frequent reassessment and clear team communication.

References

  1. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). JAMA. 2001;286(21):2703–2710.
  2. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for pain, agitation/sedation, delirium, immobility, and sleep disruption in adult ICU patients. Crit Care Med. 2018;46(9):e825–e873.
  3. Ankravs MJ, Fitzgerald JC, Ely EW, Pandharipande PP. Precision-based approaches to delirium in critical illness: a narrative review. Pharmacotherapy. 2023;43(11):1139–1153.